These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 28559949)

  • 1. Biopsy from Recurrent Lesion May Change Further Treatment Plan in Metastatic Breast Cancer.
    Altundag K
    Nucl Med Mol Imaging; 2017 Jun; 51(2):197. PubMed ID: 28559949
    [No Abstract]   [Full Text] [Related]  

  • 2. Early re-staging and molecular subtype shift surveillance of locally recurrent or metastatic breast cancer: A new PET/CT integrated precise algorithm.
    Guo W; Hao B; Luo N; Ruan D; Guo X; Chen HJ; Wu H; Sun L
    Cancer Lett; 2018 Apr; 418():221-229. PubMed ID: 29337111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic accuracy and safety of 16α-[
    Chae SY; Ahn SH; Kim SB; Han S; Lee SH; Oh SJ; Lee SJ; Kim HJ; Ko BS; Lee JW; Son BH; Kim J; Ahn JH; Jung KH; Kim JE; Kim SY; Choi WJ; Shin HJ; Gong G; Lee HS; Lee JB; Moon DH
    Lancet Oncol; 2019 Apr; 20(4):546-555. PubMed ID: 30846327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sentinel lymph node biopsy and aberrant lymphatic drainage in recurrent breast cancer: Findings likely to change treatment decisions.
    Karanlik H; Ozgur I; Kilic B; Fathalizadeh A; Sanli Y; Onder S; Saip P; Sen F; Gulluoglu BM
    J Surg Oncol; 2016 Dec; 114(7):796-802. PubMed ID: 27778360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological and prognostic significance of Ki-67 immunohistochemical expression of distant metastatic lesions in patients with metastatic breast cancer.
    Inari H; Suganuma N; Kawachi K; Yoshida T; Yamanaka T; Nakamura Y; Yoshihara M; Nakayama H; Masudo K; Oshima T; Yokose T; Rino Y; Shimizu S; Miyagi Y; Masuda M
    Breast Cancer; 2017 Nov; 24(6):748-755. PubMed ID: 28425014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importance of confirming HER2 overexpression of recurrence lesion in breast cancer patients.
    Nakamura R; Yamamoto N; Onai Y; Watanabe Y; Kawana H; Miyazaki M
    Breast Cancer; 2013 Oct; 20(4):336-41. PubMed ID: 22367960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in three biomarkers (estrogen receptor, progesterone receptor and human epidermal growth factor 2) and the Ki67 index between primary and metastatic breast cancer lesions.
    Fujii K; Watanabe R; Ando T; Kousaka J; Mouri Y; Yoshida M; Imai T; Nakano S; Fukutomi T
    Biomed Rep; 2017 Dec; 7(6):535-542. PubMed ID: 29188058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of rebiopsy for clinically diagnosed metastatic lesion in patients with breast cancer].
    Qu Q; Xu C; Chen XS; Ren RB; Cai R; Lou GY; Shen KW
    Zhonghua Yi Xue Za Zhi; 2013 Sep; 93(35):2820-2. PubMed ID: 24360181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeat sentinel node biopsy should be considered in patients with locally recurrent breast cancer.
    Vugts G; Maaskant-Braat AJ; Voogd AC; van Riet YE; Luiten EJ; Rutgers EJ; Rutten HJ; Roumen RM; Nieuwenhuijzen GA
    Breast Cancer Res Treat; 2015 Oct; 153(3):549-56. PubMed ID: 26358709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current and Emerging Therapies for HER2-Positive Women With Metastatic Breast Cancer.
    Porter K; Rosenzweig MQ
    J Adv Pract Oncol; 2017 Mar; 8(2):164-168. PubMed ID: 29900024
    [No Abstract]   [Full Text] [Related]  

  • 11. Biomarker discordance: prospective and retrospective evidence that biopsy of recurrent disease is of clinical utility.
    Moussa O; Purdie C; Vinnicombe S; Thompson AM
    Cancer Biomark; 2012-2013; 12(6):231-9. PubMed ID: 23735943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discordance of biomarker status in recurrent breast cancer.
    Soomro R; Beg MA; ur Rahman SS
    J Pak Med Assoc; 2014 Feb; 64(2):163-5. PubMed ID: 24640805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-time Response with Ado-trastuzumab Emtansine in a Recurrent Metastatic Breast Cancer.
    Manthri S; Singal S; Youssef B; Chakraborty K
    Cureus; 2019 Oct; 11(10):e6036. PubMed ID: 31824803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen receptor mutations and changes in estrogen receptor and progesterone receptor protein expression in metastatic or recurrent breast cancer.
    Umekita Y; Sagara Y; Yoshida H
    Jpn J Cancer Res; 1998 Jan; 89(1):27-32. PubMed ID: 9510472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FDG Avidity and Tumor Burden: Survival Outcomes for Patients With Recurrent Breast Cancer.
    Taghipour M; Wray R; Sheikhbahaei S; Wright JL; Subramaniam RM
    AJR Am J Roentgenol; 2016 Apr; 206(4):846-55. PubMed ID: 27003053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overview of resistance to systemic therapy in patients with breast cancer.
    Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
    Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Budget impact analysis of ixabepilone used according to FDA approved labeling in treatment-resistant metastatic breast cancer.
    Ho J; Zhang L; Todorova L; Whillans F; Corey-Lisle P; Yuan Y
    J Manag Care Pharm; 2009; 15(6):467-75. PubMed ID: 19610679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue confirmation of disease recurrence in breast cancer patients: pooled analysis of multi-centre, multi-disciplinary prospective studies.
    Amir E; Clemons M; Purdie CA; Miller N; Quinlan P; Geddie W; Coleman RE; Freedman OC; Jordan LB; Thompson AM
    Cancer Treat Rev; 2012 Oct; 38(6):708-14. PubMed ID: 22178456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sentinel Node and Recurrent Breast Cancer (SNARB): results of a nationwide registration study.
    Maaskant-Braat AJ; Roumen RM; Voogd AC; Pijpers R; Luiten EJ; Rutgers EJ; Nieuwenhuijzen GA
    Ann Surg Oncol; 2013 Feb; 20(2):620-6. PubMed ID: 22941173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lung Metastasis of Breast Cancer Five Years after Mastectomy - A Case Report].
    Fujimori T; Kasagawa T; Ishii N; Udagawa I; Ozaki D
    Gan To Kagaku Ryoho; 2016 Nov; 43(12):2044-2046. PubMed ID: 28133216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.